Robert Aflatooni
First SEC filing: April 3, 2026 · Latest: April 3, 2026
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 31, 2026 | DLTR | S | 2,500 | $126.01 | $315,025 | 24,820 Direct | -9.15% | Disposed | -11.0% (price as of 2026-10-02) |
| April 1, 2026 | DLTR | A | 8,739 | · | · | 27,320 Direct | +47.03% | Acquired | (price as of 2026-10-02) |
| April 1, 2026 | DLTR | F | 2,810 | $108.70 | $305,447 | 18,581 Direct | -13.14% | Disposed | 3.2% (price as of 2026-10-02) |
| March 31, 2026 | DLTR | F | 1,097 | $109.51 | $120,132 | 21,391 Direct | -4.88% | Disposed | 2.4% (price as of 2026-10-02) |
| March 31, 2026 | DLTR | A | 1,261 | · | · | 22,488 Direct | +5.94% | Acquired | (price as of 2026-10-02) |
| Jan. 7, 2026 | DLTR | S | 175 | $131.18 | $22,956 | 21,227 Direct | -0.82% | Disposed | -14.5% (price as of 2026-10-02) |
| Oct. 17, 2025 | DLTR | S | 1,260 | $94.70 | $119,322 | 21,402 Direct | -5.56% | Disposed | 18.4% (price as of 2026-10-02) |
| Aug. 26, 2025 | DLTR | F | 543 | $111.98 | $60,805 | 22,662 Direct | -2.34% | Disposed | 0.2% (price as of 2026-10-02) |
| June 20, 2025 | DLTR | S | 175 | $97.54 | $17,070 | 23,205 Direct | -0.75% | Disposed | 15.0% (price as of 2026-10-02) |
| April 1, 2025 | DLTR | A | 14,932 | · | · | 23,380 Direct | +176.75% | Acquired | (price as of 2026-10-02) |
| April 1, 2025 | DLTR | F | 377 | $75.34 | $28,403 | 8,448 Direct | -4.27% | Disposed | 48.9% (price as of 2026-10-02) |
| March 31, 2025 | DLTR | F | 357 | $75.07 | $26,800 | 8,825 Direct | -3.89% | Disposed | 49.4% (price as of 2026-10-02) |
| Aug. 26, 2024 | DLTR | F | 543 | $96.55 | $52,427 | 9,182 Direct | -5.58% | Disposed | 16.2% (price as of 2026-10-02) |
| June 25, 2024 | DLTR | S | 827 | $105.58 | $87,315 | 9,725 Direct | -7.84% | Disposed | 6.2% (price as of 2026-10-02) |
| April 1, 2024 | DLTR | A | 5,744 | · | · | 5,744 Direct | · | Acquired | (price as of 2026-10-02) |
| April 1, 2024 | DLTR | A | 3,752 | · | · | 10,552 Direct | +55.18% | Acquired | (price as of 2026-10-02) |
| March 31, 2024 | DLTR | F | 357 | $133.15 | $47,535 | 6,800 Direct | -4.99% | Disposed | -15.8% (price as of 2026-10-02) |
| Oct. 11, 2023 | DLTR | S | 1,259 | $107.03 | $134,751 | 7,157 Direct | -14.96% | Disposed | 4.8% (price as of 2026-10-02) |
| Aug. 26, 2023 | DLTR | F | 543 | $123.31 | $66,957 | 8,416 Direct | -6.06% | Disposed | -9.0% (price as of 2026-10-02) |
| March 31, 2023 | DLTR | A | 5,730 | · | · | 5,730 Direct | · | Acquired | (price as of 2026-10-02) |
| March 31, 2023 | DLTR | A | 3,552 | · | · | 8,959 Direct | +65.69% | Acquired | (price as of 2026-10-02) |
| Aug. 26, 2022 | DLTR | A | 5,407 | · | · | 5,407 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 1, 2024 | DLTR | Stock Option (right to buy) | Common Stock | $135.91 | · | 5,744 | Acquired |
| March 31, 2023 | DLTR | Stock Option (right to buy) | Common Stock | $143.55 | · | 5,730 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $691,154 | $250,000 | $2,360,749 | · | $959,378 | · | $21,222 | $4,282,503 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.